Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy

Summary

Hepatic encephalopathy is responsible for sleep disturbances and daytime sleepiness. The purpose of our study is to assess sleep quality, quantity, sleep schemes and physical activity in patients suffering from HE, before and after a 2 weeks treatment with rifaximine, which is currently given to lower blood ammoniac levels.

Timeline

Start

2014-03

Primary completion

2015-07

Completion

2015-07

Drugs

Indications